Showing results (121-130 of 240) with videos related to
Sort By:
Pageof 24
Thrombosis and Haemostasis|June 30, 2011
Involvement of microparticles in diabetic vascular complicationsGala Tsimerman, Ariel Roguin, Anat Bachar, et al.Fertility and Sterility|June 14, 2006
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriagesMordechai Dolitzky, Aida Inbal, Yakov Segal, et al.Plos One|July 6, 2016
Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy SubjectsMais Ali-Saleh, Galit Sarig, Jacob N Ablin, et al.European Journal of Haematology|July 22, 2006
A fatal case of enoxaparin induced skin necrosis and thrombophiliaYona Nadir, Yoav Mazor, Bergman Reuven, et al.Thrombosis Research|December 14, 2011
Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparinEli Peled, Alexey Rovitsky, Elena Axelman, et al.Thrombosis Research|December 25, 2009
Involvement of Heparanase in early pregnancy lossesYona Nadir, Israel Henig, Inna Naroditzky, et al.Haematologica|July 17, 2010
Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VIIYona Nadir, Benjamin Brenner, Liat Fux, et al.Thrombosis Research|March 30, 2010
Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitusSaher Hamed, Benjamin Brenner, Zaid Abassi, et al.Seminars in Reproductive Medicine|September 24, 2021
Approach to the Evaluation and Treatment of Venous Thromboembolism in PregnancyBenjamin Brenner, Elvira Grandone, Alexander Makatsariya, et al.Thrombosis and Haemostasis|October 23, 2015
JAK-2 V617F mutation increases heparanase procoagulant activityInna Kogan, Dafna Chap, Ron Hoffman, et al.Pageof 24